Legal & General Group
MIRM icon

Legal & General Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Legal & General Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6M Buy
159,231
+5,361
+3% +$538K ﹤0.01% 907
2026
Q1 		$14.2M Sell
153,870
-14,523
-9% -$1.37M ﹤0.01% 962
2025
Q4 		$13.3M Buy
168,393
+1,163
+0.7% +$83.5K ﹤0.01% 1014
2025
Q3 		$12.3M Buy
167,230
+124,220
+289% +$7.9M ﹤0.01% 1097
2025
Q2 		$2.19M Buy
43,010
+176
+0.4% +$7.84K ﹤0.01% 1933
2025
Q1 		$1.93M Buy
42,834
+2,014
+5% +$94.9K ﹤0.01% 1937
2024
Q4 		$1.69M Buy
40,820
+4,622
+13% +$193K ﹤0.01% 2049
2024
Q3 		$1.41M Buy
36,198
+2,013
+6% +$80.3K ﹤0.01% 2111
2024
Q2 		$1.17M Buy
34,185
+5,540
+19% +$145K ﹤0.01% 2137
2024
Q1 		$720K Sell
28,645
-56
-0.2% -$1.54K ﹤0.01% 2302
2023
Q4 		$847K Buy
28,701
+6,057
+27% +$183K ﹤0.01% 2257
2023
Q3 		$716K Buy
22,644
+1,834
+9% +$50.2K ﹤0.01% 2305
2023
Q2 		$538K Buy
20,810
+13,031
+168% +$347K ﹤0.01% 2439
2023
Q1 		$187K Buy
7,779
+498
+7% +$11.4K ﹤0.01% 2616
2022
Q4 		$142K Hold
7,281
– – ﹤0.01% 2722
2022
Q3 		$153K Buy
7,281
+698
+11% +$16.8K ﹤0.01% 2705
2022
Q2 		$128K Buy
6,583
+6,296
+2,194% +$148K ﹤0.01% 2785
2022
Q1 		$6K Hold
287
– – ﹤0.01% 3488
2021
Q4 		$5K Hold
287
– – ﹤0.01% 3547
2021
Q3 		$6K Sell
287
-65
-18% -$1.06K ﹤0.01% 3473
2021
Q2 		$6K Sell
352
-142
-29% -$2.54K ﹤0.01% 3457
2021
Q1 		$10K Hold
494
– – ﹤0.01% 3379
2020
Q4 		$9K Hold
494
– – ﹤0.01% 3369
2020
Q3 		$9K Sell
494
-324
-40% -$6.95K ﹤0.01% 3268
2020
Q2 		$16K Hold
818
– – ﹤0.01% 3158
2020
Q1 		$11K Buy
818
+267
+48% +$4.38K ﹤0.01% 3132
2019
Q4 		$14K Buy
+551
New +$5.88K ﹤0.01% 3251

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Legal & General Group's MIRM Position: Q2 2026 in Review

Legal & General Group increased its Mirum Pharmaceuticals (MIRM) stake by 3.5% in Q2 2026, buying an estimated $538K and bringing the position to 159,231 shares worth $18.6M. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Legal & General Group first reported a position in MIRM in Q4 2019 and has held it in 27 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Legal & General Group held 159,231 shares of Mirum Pharmaceuticals worth $18.6M as of Q2 2026.
  • Legal & General Group bought 5,361 Mirum Pharmaceuticals shares in Q2 2026, an estimated $538K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #907 holding.
  • Legal & General Group first reported a position in Mirum Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.